Actively Recruiting

Phase Not Applicable
Age: 45Years - 49Years
FEMALE
NCT04590560

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

Led by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Updated on 2024-12-09

60000

Participants Needed

4

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Italian, multicenter, study aimed at defining the best interval for screening women 45-49 and 70-74 years for Breast Cancer (BC). This research project includes (1) a controlled, prospective randomized non-inferiority trial to determine the optimal screening interval for women aged 45-49, with and without high mammographic density, (2) a retrospective data collection, with the same purpose, on screening performed by women aged 70-74, and (3) a qualitative research to define the best communication strategy.

CONDITIONS

Official Title

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

Who Can Participate

Age: 45Years - 49Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women invited for their first or second mammography at age 45 or 46
  • Willingness and ability to follow scheduled visits
  • Signed informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Currently pregnant
  • Previous diagnosis of invasive breast cancer or ductal carcinoma in situ (DCIS)
  • Known family history indicating high breast cancer risk
  • Participation in another breast cancer screening trial
  • Unable to provide signed informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Irst Irccs

Meldola (FC), FC, Italy, 47014

Actively Recruiting

2

Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO)

Florence, Italy

Not Yet Recruiting

3

AUSL Romagna

Forlì, Italy

Actively Recruiting

4

AOU Città della Salute e della Scienza

Torino, Italy

Not Yet Recruiting

Loading map...

Research Team

O

Oriana Nanni

CONTACT

C

Chiara Zingaretti

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here